Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Hull

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Drug Safety|October 1, 1993
Adverse effects of coumarin anticoagulantsG F Pineo, R D Hull
Annals of Medicine|October 1, 1993
Low-molecular-weight heparins for the treatment of venous thromboembolismR D Hull, G F Pineo
American Industrial Hygiene Association Journal|February 1, 1986
Evaluation of the Du Pont Pro-Tek Formaldehyde Badge and the 3M Formaldehyde MonitorE R Kennedy, R D Hull
Current Opinion in Pulmonary Medicine|July 1, 1997
Disorders of pulmonary circulationG F Pineo, R D Hull
The Medical Clinics of North America|July 1, 1998
Prophylaxis of deep venous thrombosis and pulmonary embolism. Current recommendationsR D Hull, G F Pineo
Seminars in Hematology|December 17, 1997
Low molecular weight heparins and antithrombotic therapy: results of an audience-interactive symposiumV J Marder, R D Hull
Haemostasis|January 12, 2000
Extended prophylaxis against venous thromboembolism following total hip and knee replacementR D Hull, G F Pineo
Seminars in Thrombosis and Hemostasis|November 5, 1999
Long term outpatient prophylaxis for venous thromboembolismR D Hull, G F Pineo
Clinics in Chest Medicine|June 1, 1995
Current concepts of anticoagulation therapyR D Hull, G F Pineo
Clinics in Chest Medicine|June 1, 1995
Management of venous thromboembolic disease. The impact of low-molecular-weight heparinV F Tapson, R D Hull
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Drug Safety|October 1, 1993
Adverse effects of coumarin anticoagulantsG F Pineo, R D Hull
Annals of Medicine|October 1, 1993
Low-molecular-weight heparins for the treatment of venous thromboembolismR D Hull, G F Pineo
American Industrial Hygiene Association Journal|February 1, 1986
Evaluation of the Du Pont Pro-Tek Formaldehyde Badge and the 3M Formaldehyde MonitorE R Kennedy, R D Hull
Current Opinion in Pulmonary Medicine|July 1, 1997
Disorders of pulmonary circulationG F Pineo, R D Hull
The Medical Clinics of North America|July 1, 1998
Prophylaxis of deep venous thrombosis and pulmonary embolism. Current recommendationsR D Hull, G F Pineo
Seminars in Hematology|December 17, 1997
Low molecular weight heparins and antithrombotic therapy: results of an audience-interactive symposiumV J Marder, R D Hull
Haemostasis|January 12, 2000
Extended prophylaxis against venous thromboembolism following total hip and knee replacementR D Hull, G F Pineo
Seminars in Thrombosis and Hemostasis|November 5, 1999
Long term outpatient prophylaxis for venous thromboembolismR D Hull, G F Pineo
Clinics in Chest Medicine|June 1, 1995
Current concepts of anticoagulation therapyR D Hull, G F Pineo
Clinics in Chest Medicine|June 1, 1995
Management of venous thromboembolic disease. The impact of low-molecular-weight heparinV F Tapson, R D Hull
Pageof 14